Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients

In late 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan, capital city of Hubei province in China. Cases of SARS-CoV-2 infection quickly grew by several thousand per day. Less than 100 days later, the World Health Organization declared that the rapidly spreading viral outbreak had become a gl...

Full description

Saved in:
Bibliographic Details
Published inJournal of translational medicine Vol. 18; no. 1; pp. 203 - 19
Main Authors Rogers, Christopher J., Harman, Robert J., Bunnell, Bruce A., Schreiber, Martin A., Xiang, Charlie, Wang, Fu-Sheng, Santidrian, Antonio F., Minev, Boris R.
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 18.05.2020
BioMed Central
BMC
Subjects
Adipocytes
Alveoli
Animal models
Animals
ARDS
Betacoronavirus - physiology
Bone marrow
Clinical trials
Clinical Trials as Topic
Coronavirus Infections - therapy
Coronaviruses
COVID-19
Cytokines
Edema
Epidemics
Fever
Health aspects
Humans
Hypoxia
Immune clearance
Immune response
Immunomodulation
Immunomodulators
Infections
Inflammation
Intravenous administration
Lung diseases
Medical research
Mesenchymal Stem Cell Transplantation - adverse effects
Mesenchymal stem cells
Mesenchymal Stem Cells - cytology
Morbidity
Mortality
Neutrophils
Outbreaks
Pandemics
Pathogenesis
Patients
Pneumonia
Pneumonia, Viral - therapy
Pulmonary fibrosis
Respiratory diseases
Respiratory distress syndrome
Respiratory function
Review
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Stem cell transplantation
Stem cells
United Kingdom
United Kingdom
COVID-19
Pneumonia
SARS-CoV-2
ARDS
Mesenchymal stem cells
Online AccessGet full text

Cover

Abstract In late 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan, capital city of Hubei province in China. Cases of SARS-CoV-2 infection quickly grew by several thousand per day. Less than 100 days later, the World Health Organization declared that the rapidly spreading viral outbreak had become a global pandemic. Coronavirus disease 2019 (COVID-19) is typically associated with fever and respiratory symptoms. It often progresses to severe respiratory distress and multi-organ failure which carry a high mortality rate. Older patients or those with medical comorbidities are at greater risk for severe disease. Inflammation, pulmonary edema and an over-reactive immune response can lead to hypoxia, respiratory distress and lung damage. Mesenchymal stromal/stem cells (MSCs) possess potent and broad-ranging immunomodulatory activities. Multiple in vivo studies in animal models and ex vivo human lung models have demonstrated the MSC’s impressive capacity to inhibit lung damage, reduce inflammation, dampen immune responses and aid with alveolar fluid clearance. Additionally, MSCs produce molecules that are antimicrobial and reduce pain. Upon administration by the intravenous route, the cells travel directly to the lungs where the majority are sequestered, a great benefit for the treatment of pulmonary disease. The in vivo safety of local and intravenous administration of MSCs has been demonstrated in multiple human clinical trials, including studies of acute respiratory distress syndrome (ARDS). Recently, the application of MSCs in the context of ongoing COVID-19 disease and other viral respiratory illnesses has demonstrated reduced patient mortality and, in some cases, improved long-term pulmonary function. Adipose-derived stem cells (ASC), an abundant type of MSC, are proposed as a therapeutic option for the treatment of COVID-19 in order to reduce morbidity and mortality. Additionally, when proven to be safe and effective, ASC treatments may reduce the demand on critical hospital resources. The ongoing COVID-19 outbreak has resulted in significant healthcare and socioeconomic burdens across the globe. There is a desperate need for safe and effective treatments. Cellular based therapies hold great promise for the treatment of COVID-19. This literature summary reviews the scientific rationale and need for clinical studies of adipose-derived stem cells and other types of mesenchymal stem cells in the treatment of patients who suffer with COVID-19.
AbstractList Abstract In late 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan, capital city of Hubei province in China. Cases of SARS-CoV-2 infection quickly grew by several thousand per day. Less than 100 days later, the World Health Organization declared that the rapidly spreading viral outbreak had become a global pandemic. Coronavirus disease 2019 (COVID-19) is typically associated with fever and respiratory symptoms. It often progresses to severe respiratory distress and multi-organ failure which carry a high mortality rate. Older patients or those with medical comorbidities are at greater risk for severe disease. Inflammation, pulmonary edema and an over-reactive immune response can lead to hypoxia, respiratory distress and lung damage. Mesenchymal stromal/stem cells (MSCs) possess potent and broad-ranging immunomodulatory activities. Multiple in vivo studies in animal models and ex vivo human lung models have demonstrated the MSC’s impressive capacity to inhibit lung damage, reduce inflammation, dampen immune responses and aid with alveolar fluid clearance. Additionally, MSCs produce molecules that are antimicrobial and reduce pain. Upon administration by the intravenous route, the cells travel directly to the lungs where the majority are sequestered, a great benefit for the treatment of pulmonary disease. The in vivo safety of local and intravenous administration of MSCs has been demonstrated in multiple human clinical trials, including studies of acute respiratory distress syndrome (ARDS). Recently, the application of MSCs in the context of ongoing COVID-19 disease and other viral respiratory illnesses has demonstrated reduced patient mortality and, in some cases, improved long-term pulmonary function. Adipose-derived stem cells (ASC), an abundant type of MSC, are proposed as a therapeutic option for the treatment of COVID-19 in order to reduce morbidity and mortality. Additionally, when proven to be safe and effective, ASC treatments may reduce the demand on critical hospital resources. The ongoing COVID-19 outbreak has resulted in significant healthcare and socioeconomic burdens across the globe. There is a desperate need for safe and effective treatments. Cellular based therapies hold great promise for the treatment of COVID-19. This literature summary reviews the scientific rationale and need for clinical studies of adipose-derived stem cells and other types of mesenchymal stem cells in the treatment of patients who suffer with COVID-19.
In late 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan, capital city of Hubei province in China. Cases of SARS-CoV-2 infection quickly grew by several thousand per day. Less than 100 days later, the World Health Organization declared that the rapidly spreading viral outbreak had become a global pandemic. Coronavirus disease 2019 (COVID-19) is typically associated with fever and respiratory symptoms. It often progresses to severe respiratory distress and multi-organ failure which carry a high mortality rate. Older patients or those with medical comorbidities are at greater risk for severe disease. Inflammation, pulmonary edema and an over-reactive immune response can lead to hypoxia, respiratory distress and lung damage. Mesenchymal stromal/stem cells (MSCs) possess potent and broad-ranging immunomodulatory activities. Multiple in vivo studies in animal models and ex vivo human lung models have demonstrated the MSC's impressive capacity to inhibit lung damage, reduce inflammation, dampen immune responses and aid with alveolar fluid clearance. Additionally, MSCs produce molecules that are antimicrobial and reduce pain. Upon administration by the intravenous route, the cells travel directly to the lungs where the majority are sequestered, a great benefit for the treatment of pulmonary disease. The in vivo safety of local and intravenous administration of MSCs has been demonstrated in multiple human clinical trials, including studies of acute respiratory distress syndrome (ARDS). Recently, the application of MSCs in the context of ongoing COVID-19 disease and other viral respiratory illnesses has demonstrated reduced patient mortality and, in some cases, improved long-term pulmonary function. Adipose-derived stem cells (ASC), an abundant type of MSC, are proposed as a therapeutic option for the treatment of COVID-19 in order to reduce morbidity and mortality. Additionally, when proven to be safe and effective, ASC treatments may reduce the demand on critical hospital resources. The ongoing COVID-19 outbreak has resulted in significant healthcare and socioeconomic burdens across the globe. There is a desperate need for safe and effective treatments. Cellular based therapies hold great promise for the treatment of COVID-19. This literature summary reviews the scientific rationale and need for clinical studies of adipose-derived stem cells and other types of mesenchymal stem cells in the treatment of patients who suffer with COVID-19.In late 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan, capital city of Hubei province in China. Cases of SARS-CoV-2 infection quickly grew by several thousand per day. Less than 100 days later, the World Health Organization declared that the rapidly spreading viral outbreak had become a global pandemic. Coronavirus disease 2019 (COVID-19) is typically associated with fever and respiratory symptoms. It often progresses to severe respiratory distress and multi-organ failure which carry a high mortality rate. Older patients or those with medical comorbidities are at greater risk for severe disease. Inflammation, pulmonary edema and an over-reactive immune response can lead to hypoxia, respiratory distress and lung damage. Mesenchymal stromal/stem cells (MSCs) possess potent and broad-ranging immunomodulatory activities. Multiple in vivo studies in animal models and ex vivo human lung models have demonstrated the MSC's impressive capacity to inhibit lung damage, reduce inflammation, dampen immune responses and aid with alveolar fluid clearance. Additionally, MSCs produce molecules that are antimicrobial and reduce pain. Upon administration by the intravenous route, the cells travel directly to the lungs where the majority are sequestered, a great benefit for the treatment of pulmonary disease. The in vivo safety of local and intravenous administration of MSCs has been demonstrated in multiple human clinical trials, including studies of acute respiratory distress syndrome (ARDS). Recently, the application of MSCs in the context of ongoing COVID-19 disease and other viral respiratory illnesses has demonstrated reduced patient mortality and, in some cases, improved long-term pulmonary function. Adipose-derived stem cells (ASC), an abundant type of MSC, are proposed as a therapeutic option for the treatment of COVID-19 in order to reduce morbidity and mortality. Additionally, when proven to be safe and effective, ASC treatments may reduce the demand on critical hospital resources. The ongoing COVID-19 outbreak has resulted in significant healthcare and socioeconomic burdens across the globe. There is a desperate need for safe and effective treatments. Cellular based therapies hold great promise for the treatment of COVID-19. This literature summary reviews the scientific rationale and need for clinical studies of adipose-derived stem cells and other types of mesenchymal stem cells in the treatment of patients who suffer with COVID-19.
In late 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan, capital city of Hubei province in China. Cases of SARS-CoV-2 infection quickly grew by several thousand per day. Less than 100 days later, the World Health Organization declared that the rapidly spreading viral outbreak had become a global pandemic. Coronavirus disease 2019 (COVID-19) is typically associated with fever and respiratory symptoms. It often progresses to severe respiratory distress and multi-organ failure which carry a high mortality rate. Older patients or those with medical comorbidities are at greater risk for severe disease. Inflammation, pulmonary edema and an over-reactive immune response can lead to hypoxia, respiratory distress and lung damage. Mesenchymal stromal/stem cells (MSCs) possess potent and broad-ranging immunomodulatory activities. Multiple in vivo studies in animal models and ex vivo human lung models have demonstrated the MSC's impressive capacity to inhibit lung damage, reduce inflammation, dampen immune responses and aid with alveolar fluid clearance. Additionally, MSCs produce molecules that are antimicrobial and reduce pain. Upon administration by the intravenous route, the cells travel directly to the lungs where the majority are sequestered, a great benefit for the treatment of pulmonary disease. The in vivo safety of local and intravenous administration of MSCs has been demonstrated in multiple human clinical trials, including studies of acute respiratory distress syndrome (ARDS). Recently, the application of MSCs in the context of ongoing COVID-19 disease and other viral respiratory illnesses has demonstrated reduced patient mortality and, in some cases, improved long-term pulmonary function. Adipose-derived stem cells (ASC), an abundant type of MSC, are proposed as a therapeutic option for the treatment of COVID-19 in order to reduce morbidity and mortality. Additionally, when proven to be safe and effective, ASC treatments may reduce the demand on critical hospital resources. The ongoing COVID-19 outbreak has resulted in significant healthcare and socioeconomic burdens across the globe. There is a desperate need for safe and effective treatments. Cellular based therapies hold great promise for the treatment of COVID-19. This literature summary reviews the scientific rationale and need for clinical studies of adipose-derived stem cells and other types of mesenchymal stem cells in the treatment of patients who suffer with COVID-19. Keywords: COVID-19, SARS-CoV-2, ARDS, Pneumonia, Mesenchymal stem cells
In late 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan, capital city of Hubei province in China. Cases of SARS-CoV-2 infection quickly grew by several thousand per day. Less than 100 days later, the World Health Organization declared that the rapidly spreading viral outbreak had become a global pandemic. Coronavirus disease 2019 (COVID-19) is typically associated with fever and respiratory symptoms. It often progresses to severe respiratory distress and multi-organ failure which carry a high mortality rate. Older patients or those with medical comorbidities are at greater risk for severe disease. Inflammation, pulmonary edema and an over-reactive immune response can lead to hypoxia, respiratory distress and lung damage. Mesenchymal stromal/stem cells (MSCs) possess potent and broad-ranging immunomodulatory activities. Multiple in vivo studies in animal models and ex vivo human lung models have demonstrated the MSC’s impressive capacity to inhibit lung damage, reduce inflammation, dampen immune responses and aid with alveolar fluid clearance. Additionally, MSCs produce molecules that are antimicrobial and reduce pain. Upon administration by the intravenous route, the cells travel directly to the lungs where the majority are sequestered, a great benefit for the treatment of pulmonary disease. The in vivo safety of local and intravenous administration of MSCs has been demonstrated in multiple human clinical trials, including studies of acute respiratory distress syndrome (ARDS). Recently, the application of MSCs in the context of ongoing COVID-19 disease and other viral respiratory illnesses has demonstrated reduced patient mortality and, in some cases, improved long-term pulmonary function. Adipose-derived stem cells (ASC), an abundant type of MSC, are proposed as a therapeutic option for the treatment of COVID-19 in order to reduce morbidity and mortality. Additionally, when proven to be safe and effective, ASC treatments may reduce the demand on critical hospital resources. The ongoing COVID-19 outbreak has resulted in significant healthcare and socioeconomic burdens across the globe. There is a desperate need for safe and effective treatments. Cellular based therapies hold great promise for the treatment of COVID-19. This literature summary reviews the scientific rationale and need for clinical studies of adipose-derived stem cells and other types of mesenchymal stem cells in the treatment of patients who suffer with COVID-19.
In late 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan, capital city of Hubei province in China. Cases of SARS-CoV-2 infection quickly grew by several thousand per day. Less than 100 days later, the World Health Organization declared that the rapidly spreading viral outbreak had become a global pandemic. Coronavirus disease 2019 (COVID-19) is typically associated with fever and respiratory symptoms. It often progresses to severe respiratory distress and multi-organ failure which carry a high mortality rate. Older patients or those with medical comorbidities are at greater risk for severe disease. Inflammation, pulmonary edema and an over-reactive immune response can lead to hypoxia, respiratory distress and lung damage. Mesenchymal stromal/stem cells (MSCs) possess potent and broad-ranging immunomodulatory activities. Multiple in vivo studies in animal models and ex vivo human lung models have demonstrated the MSC's impressive capacity to inhibit lung damage, reduce inflammation, dampen immune responses and aid with alveolar fluid clearance. Additionally, MSCs produce molecules that are antimicrobial and reduce pain. Upon administration by the intravenous route, the cells travel directly to the lungs where the majority are sequestered, a great benefit for the treatment of pulmonary disease. The in vivo safety of local and intravenous administration of MSCs has been demonstrated in multiple human clinical trials, including studies of acute respiratory distress syndrome (ARDS). Recently, the application of MSCs in the context of ongoing COVID-19 disease and other viral respiratory illnesses has demonstrated reduced patient mortality and, in some cases, improved long-term pulmonary function. Adipose-derived stem cells (ASC), an abundant type of MSC, are proposed as a therapeutic option for the treatment of COVID-19 in order to reduce morbidity and mortality. Additionally, when proven to be safe and effective, ASC treatments may reduce the demand on critical hospital resources. The ongoing COVID-19 outbreak has resulted in significant healthcare and socioeconomic burdens across the globe. There is a desperate need for safe and effective treatments. Cellular based therapies hold great promise for the treatment of COVID-19. This literature summary reviews the scientific rationale and need for clinical studies of adipose-derived stem cells and other types of mesenchymal stem cells in the treatment of patients who suffer with COVID-19.
ArticleNumber 203
Audience Academic
Author Harman, Robert J.
Wang, Fu-Sheng
Santidrian, Antonio F.
Minev, Boris R.
Schreiber, Martin A.
Rogers, Christopher J.
Bunnell, Bruce A.
Xiang, Charlie
Author_xml – sequence: 1
  givenname: Christopher J.
  surname: Rogers
  fullname: Rogers, Christopher J.
– sequence: 2
  givenname: Robert J.
  orcidid: 0000-0001-6430-145X
  surname: Harman
  fullname: Harman, Robert J.
– sequence: 3
  givenname: Bruce A.
  surname: Bunnell
  fullname: Bunnell, Bruce A.
– sequence: 4
  givenname: Martin A.
  surname: Schreiber
  fullname: Schreiber, Martin A.
– sequence: 5
  givenname: Charlie
  surname: Xiang
  fullname: Xiang, Charlie
– sequence: 6
  givenname: Fu-Sheng
  surname: Wang
  fullname: Wang, Fu-Sheng
– sequence: 7
  givenname: Antonio F.
  surname: Santidrian
  fullname: Santidrian, Antonio F.
– sequence: 8
  givenname: Boris R.
  surname: Minev
  fullname: Minev, Boris R.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32423449$$D View this record in MEDLINE/PubMed
BookMark eNp9kl1rFDEUhgep2A_9A17IgDfeTE1OMsnkRihbPxYKBVEvDdnkZDdlZrIms4X-e7O7rXaLSAj5et8nnOQ9rY7GOGJVvabknNJOvM8UlJANAVI660gDz6oTyqVq2k6Ko0fz4-o05xtCgLdcvaiOGXBgnKuT6udXM4U4mh5rH1M9rbC2fRiDNX29yVhHXxsX1jFj4zCFW3T1gBlHu7obiiRPONQW-z7v7LPrH_PLhqp6Xag4Tvll9dybPuOr-_Gs-v7p47fZl-bq-vN8dnHVWAFqapQUAgW2FhbeOOetRSkZECoM7Yg1BND4BfPQGSu8k86X1UIhKltcCtlZNd9zXTQ3ep3CYNKdjibo3UZMS23SFGyPmoPpFJcLRstAOzStUwDojWq594YW1oc9a71ZDOhsqSOZ_gB6eDKGlV7GWy2BgQJeAO_uASn-2mCe9BDy9pHMiHGTNXDCBVOKtUX69on0Jm5S-Y69ilNFmPirWpZ_0mH0sdxrt1B9IUByQaWAojr_h6o0h0OwJTo-lP0Dw5vHhf6p8CEdRdDtBTbFnBN6bcO0y0shh15TordB1Psg6hJEvQui3rLhifWB_h_Tb8GX32E
CitedBy_id crossref_primary_10_1016_j_radmp_2021_09_004
crossref_primary_10_1016_j_tranon_2021_101095
crossref_primary_10_3389_fimmu_2023_1232472
crossref_primary_10_3390_polym13224011
crossref_primary_10_5937_hraIsh2002078V
crossref_primary_10_1007_s00238_021_01874_6
crossref_primary_10_4252_wjsc_v12_i10_1067
crossref_primary_10_3389_fbioe_2021_640617
crossref_primary_10_3390_cells11142175
crossref_primary_10_19161_etd_950623
crossref_primary_10_1016_j_cryobiol_2024_104856
crossref_primary_10_14336_AD_2020_1218
crossref_primary_10_3389_fbioe_2021_837464
crossref_primary_10_1002_bit_27729
crossref_primary_10_1007_s12015_021_10122_0
crossref_primary_10_1055_a_1720_7975
crossref_primary_10_1186_s13287_020_02006_w
crossref_primary_10_3389_fimmu_2020_583017
crossref_primary_10_1038_s41598_021_97383_4
crossref_primary_10_3390_cells11121926
crossref_primary_10_1002_advs_202207334
crossref_primary_10_1016_j_gene_2021_145471
crossref_primary_10_1007_s13577_020_00444_5
crossref_primary_10_3389_fcell_2021_725606
crossref_primary_10_3389_fcell_2023_1146835
crossref_primary_10_1097_MD_0000000000023377
crossref_primary_10_4252_wjsc_v12_i8_731
crossref_primary_10_29328_journal_jsctt_1001033
crossref_primary_10_1007_s13577_022_00785_3
crossref_primary_10_1080_19420889_2021_1965356
crossref_primary_10_14336_AD_2020_0711
crossref_primary_10_1016_j_lfs_2020_118588
crossref_primary_10_12998_wjcc_v10_i27_9714
crossref_primary_10_1667_RADE_20_00188_1
crossref_primary_10_2147_BTT_S404421
crossref_primary_10_3390_ijms22189967
crossref_primary_10_1186_s13287_022_02810_6
crossref_primary_10_56951_medicinus_v36i1_113
crossref_primary_10_54537_tusebdergisi_983736
crossref_primary_10_3390_biom14010008
crossref_primary_10_1038_s41598_024_75776_5
crossref_primary_10_3390_biomedicines11030858
crossref_primary_10_1080_2000656X_2022_2097250
crossref_primary_10_1016_j_ebiom_2021_103789
crossref_primary_10_1016_j_jcyt_2024_03_491
crossref_primary_10_1093_labmed_lmaa049
crossref_primary_10_1016_j_prp_2022_154280
crossref_primary_10_21320_1818_474X_2023_1_71_82
crossref_primary_10_29328_journal_jsctt_1001021
crossref_primary_10_4103_hmj_hmj_66_20
crossref_primary_10_3389_fcell_2020_609204
crossref_primary_10_1002_cbin_11440
crossref_primary_10_1016_j_intimp_2021_108328
crossref_primary_10_32604_biocell_2023_043351
crossref_primary_10_1089_scd_2020_0198
crossref_primary_10_1016_j_ijid_2021_01_035
crossref_primary_10_4252_wjsc_v12_i9_1013
crossref_primary_10_4252_wjsc_v13_i6_568
crossref_primary_10_1007_s12035_021_02318_9
crossref_primary_10_1186_s12967_021_02884_5
crossref_primary_10_3389_fphar_2021_778219
crossref_primary_10_2217_rme_2020_0189
crossref_primary_10_3390_ph17060707
crossref_primary_10_1007_s00109_021_02175_y
crossref_primary_10_1186_s43556_020_00017_w
crossref_primary_10_3390_pharmaceutics13081264
crossref_primary_10_5993_AJHB_47_1_19
crossref_primary_10_3390_ijtm1010002
crossref_primary_10_1007_s10616_021_00461_8
crossref_primary_10_1016_j_jcyt_2021_04_004
crossref_primary_10_1007_s12015_020_10026_5
crossref_primary_10_1177_0963689720940719
crossref_primary_10_1186_s13287_022_02941_w
crossref_primary_10_4252_wjsc_v13_i8_1058
crossref_primary_10_1016_j_clinsp_2023_100237
crossref_primary_10_3390_antiox11101862
crossref_primary_10_1016_j_procbio_2023_02_028
crossref_primary_10_2174_011574888X260032230925052240
crossref_primary_10_4274_balkanmedj_galenos_2022_2022_5_50
crossref_primary_10_1007_s13770_024_00633_5
crossref_primary_10_34087_cbusbed_776367
Cites_doi 10.1016/j.molmed.2018.12.006
10.1089/ten.tea.2010.0159
10.1097/TA.0000000000001713
10.1097/00007890-196803000-00009
10.3390/ijms18040689
10.3389/fmed.2018.00179
10.1111/j.1365-2141.2005.05409.x
10.3727/096368914X685645
10.1016/j.bbmt.2015.05.008
10.12659/MSM.915804
10.1002/sctm.17-0051
10.1182/blood-2004-07-2921
10.1371/journal.pone.0047559
10.3390/ijms18102140
10.1080/14712598.2016.1218845
10.1128/JVI.79.12.7768-7776.2005
10.3390/jcm8071025
10.1016/S0140-6736(16)31203-X
10.1038/bmt.2014.188
10.1016/j.exer.2015.01.020
10.12688/f1000research.7646.1
10.1089/vim.2015.0039
10.1177/0961203318819131
10.1177/0963689717721203
10.1186/s12974-018-1099-3
10.1152/ajplung.00180.2011
10.1186/s12967-018-1420-z
10.1136/bmj.m1091
10.1101/2020.01.31.929042
10.1164/rccm.201005-0746OC
10.1165/rcmb.2012-0406OC
10.1164/rccm.201001-0010OC
10.1164/rccm.201708-1733OC
10.1097/01.prs.0000234609.74811.2e
10.2460/ajvr.69.7.928
10.2353/ajpath.2009.080629
10.1100/2012/105698
10.1097/CCM.0000000000002833
10.1002/jor.1100090504
10.1016/j.gene.2018.02.008
10.1007/s00277-018-3384-8
10.1136/thoraxjnl-2011-201059
10.1097/CCM.0b013e3182451c87
10.1371/journal.pone.0147170
10.1164/rccm.201208-1460OC
10.1093/cid/ciaa248
10.3892/ijmm.2013.1328
10.1002/stem.2417
10.1016/j.jcyt.2016.09.008
10.1056/NEJMoa1005372
10.1007/s00408-016-9884-1
10.1152/ajplung.00431.2006
10.1007/s00134-014-3272-1
10.1073/pnas.0907996106
10.1016/j.bbmt.2014.10.021
10.1165/rcmb.2004-0330OC
10.1093/infdis/jiy478
10.1186/scrt167
10.1111/j.2042-3306.2002.tb05451.x
10.1002/stem.2891
10.1111/ajt.13271
10.1136/gutjnl-2011-300083
10.1038/nm.2736
10.1371/journal.pone.0089595
10.3389/fimmu.2018.02056
10.2302/kjm.54.132
10.7150/thno.16911
10.1074/jbc.M110.119917
10.3389/fimmu.2016.00155
10.1080/15384047.2016.1210741
10.1007/s00441-018-2871-5
10.1056/NEJM200005043421806
10.1002/stem.2619
10.1016/j.cveq.2014.11.011
10.1007/s10238-013-0266-1
10.1186/s40635-015-0065-y
10.1186/s12931-014-0118-x
10.1136/annrheumdis-2015-208918
10.1016/j.rvsc.2015.09.010
10.1164/ajrccm.163.6.2004035
10.1371/journal.pone.0008013
10.1136/gut.2008.168534
10.1089/vim.2016.0140
10.1164/rccm.201410-1765OC
10.1073/pnas.1601911113
10.1186/scrt428
10.1101/2020.02.17.20024166
10.1097/MD.0000000000021429
10.1200/JCO.2015.65.3642
10.1016/S2213-2600(14)70291-7
10.7150/ijms.5385
10.3390/ijms19102996
10.1182/blood-2004-09-3696
10.1001/jama.2020.1585
10.1016/j.jss.2008.03.019
10.5858/arpa.2016-0342-RA
10.1080/14653240500319234
10.1002/stem.2344
10.1159/000110447
10.1136/bcr-2018-227865
10.1016/j.imlet.2009.07.010
10.1165/rcmb.2016-0061OC
10.1016/j.it.2011.11.004
10.1055/s-0030-1254046
10.1080/14653240600855905
10.1016/j.tvjl.2010.08.009
10.3389/fimmu.2017.00371
10.5966/sctm.2015-0265
10.1097/01.prs.0000256047.47909.71
10.1099/vir.0.045013-0
10.3109/0886022X.2014.950931
10.1016/S0140-6736(20)30183-5
10.1136/thoraxjnl-2018-211576
10.1186/s12967-016-0918-5
10.1016/j.ijcard.2016.04.061
10.1111/vru.12243
10.1016/j.yexcr.2018.06.003
10.1016/j.exphem.2005.07.003
10.1016/j.imlet.2016.09.009
10.1186/scrt75
10.1136/lupus-2018-lsm.76
10.3390/jcm9030682
10.1681/ASN.2008070798
10.1186/1479-5876-11-179
10.1371/journal.pone.0181946
10.1002/sctm.17-0040
10.11138/ccmbm/2017.14.1.217
10.1158/0008-5472.CAN-11-1739
10.1186/s13287-018-0774-8
10.1038/mt.2011.211
10.1186/cc6174
10.1089/scd.2015.0120
10.1016/S2213-2600(20)30076-X
10.1016/S1474-4422(11)70305-2
10.1165/rcmb.2017-0326OC
10.1128/JVI.01998-10
10.5966/sctm.2012-0184
10.1152/ajplung.00336.2015
10.4103/2045-8932.83454
10.1152/jappl.2001.91.3.1396
10.5966/sctm.2014-0252
10.3389/fimmu.2012.00297
10.1016/j.jvsv.2018.08.010
10.1038/nri3399
10.1152/jappl.1996.81.4.1589
10.1097/ALN.0000000000000446
10.4049/jimmunol.179.3.1855
10.1128/JVI.78.5.2632-2636.2004
10.1093/abbs/gmr077
10.1155/2014/340257
10.1002/sctm.17-0031
10.1016/j.jcyt.2013.12.006
10.1517/14712590903213651
10.3727/096368916X694373
10.1002/sctm.19-0202
10.1002/ccd.26601
10.1016/S0140-6736(20)30251-8
10.1002/stem.544
10.14336/AD.2020.0228
10.1161/CIRCRESAHA.107.159475
10.5966/sctm.2015-0348
10.3389/fvets.2016.00081
10.1016/j.thromres.2016.11.007
10.1038/s41586-020-2012-7
10.3390/ijms20102523
10.14336/AD.2020.0301
10.1042/CBI20110304
10.1186/1465-9921-15-39
10.1016/j.ajpath.2012.08.009
10.1002/jcb.20904
10.4161/auto.5.2.7495
10.1002/stem.2779
10.1016/j.breast.2016.11.001
10.1152/ajplung.00354.2011
10.1371/journal.pone.0195891
10.1002/sctm.18-0015
10.2217/rme-2018-0161
10.1016/S2352-3026(15)00224-0
10.1089/scd.2007.0154
10.1093/eurheartj/ehp568
10.1016/j.ahj.2014.03.022
10.1007/978-1-4939-3584-0_4
10.1002/jcp.25816
10.1016/j.jcyt.2017.05.002
10.1016/j.cellbi.2007.12.007
10.1016/j.joca.2013.06.025
10.1155/2018/4197857
10.1089/scd.2010.0466
10.1186/scrt513
10.1111/cmi.12522
10.1056/NEJMoa2001316
10.1097/SHK.0000000000000080
10.1097/TA.0000000000001485
10.1016/S2213-2600(18)30418-1
10.1038/nbt.2816
10.1007/s13577-014-0095-x
10.1002/stem.2372
10.1056/NEJMoa1214103
10.1093/gerona/glx137
10.1186/s40169-019-0242-9
10.1002/stem.1504
10.1089/ten.tea.2010.0248
10.1111/jcmm.12638
10.1089/scd.2011.0139
10.1002/stem.1111
10.1016/S0140-6736(20)30566-3
10.1016/j.jcyt.2013.04.009
10.1038/nm1494
10.1002/stem.1996
10.1097/CCM.0b013e31828a663e
10.1164/rccm.201701-0170OC
10.1182/blood.V99.10.3838
10.1136/thoraxjnl-2011-201176
10.1111/evj.12263
10.2217/rme-2017-0152
10.1056/NEJMoa1011802
10.1634/stemcells.2005-0342
10.1186/s13287-019-1391-x
10.5966/sctm.2015-0021
10.21037/jtd.2018.08.28
10.1136/thoraxjnl-2013-204980
10.1097/MOH.0000000000000361
10.1089/scd.2008.0253
10.3390/jcm8020249
10.15252/embr.201948052
10.1016/j.stem.2009.05.003
10.1111/jvim.12593
10.1097/ALN.0000000000000545
10.1371/journal.pmed.0040269
ContentType Journal Article
Copyright COPYRIGHT 2020 BioMed Central Ltd.
2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2020
Copyright_xml – notice: COPYRIGHT 2020 BioMed Central Ltd.
– notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2020
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T5
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12967-020-02380-2
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Immunology Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
Coronavirus Research Database
ProQuest Central Korea
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

Publicly Available Content Database
MEDLINE

CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1479-5876
EndPage 19
ExternalDocumentID oai_doaj_org_article_42a8947b3189418ea5d922efa954ffa1
PMC7232924
A627461762
32423449
10_1186_s12967_020_02380_2
Genre Journal Article
Review
GeographicLocations United Kingdom
GeographicLocations_xml – name: United Kingdom
GrantInformation_xml – fundername: NIGMS NIH HHS
  grantid: U54 GM104940
GroupedDBID ---
0R~
29L
2WC
53G
5VS
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
TR2
TUS
UKHRP
WOQ
WOW
XSB
~8M
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PMFND
3V.
7T5
7XB
8FK
AZQEC
COVID
DWQXO
H94
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c629t-9766e6e5c2bfaddfcce7732016a180ca02eafb3f28ac6fd7dffb3b9ee9c6e59e3
IEDL.DBID 7X7
ISSN 1479-5876
IngestDate Wed Aug 27 01:19:43 EDT 2025
Thu Aug 21 14:04:58 EDT 2025
Mon Jul 21 09:19:30 EDT 2025
Fri Jul 25 21:38:55 EDT 2025
Tue Jun 17 21:29:50 EDT 2025
Tue Jun 10 20:49:51 EDT 2025
Mon Jul 21 05:49:57 EDT 2025
Tue Jul 01 03:51:14 EDT 2025
Thu Apr 24 23:07:04 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords COVID-19
Pneumonia
SARS-CoV-2
ARDS
Mesenchymal stem cells
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c629t-9766e6e5c2bfaddfcce7732016a180ca02eafb3f28ac6fd7dffb3b9ee9c6e59e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0001-6430-145X
OpenAccessLink https://www.proquest.com/docview/2404419036?pq-origsite=%requestingapplication%
PMID 32423449
PQID 2404419036
PQPubID 43076
PageCount 19
ParticipantIDs doaj_primary_oai_doaj_org_article_42a8947b3189418ea5d922efa954ffa1
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7232924
proquest_miscellaneous_2404639935
proquest_journals_2404419036
gale_infotracmisc_A627461762
gale_infotracacademiconefile_A627461762
pubmed_primary_32423449
crossref_citationtrail_10_1186_s12967_020_02380_2
crossref_primary_10_1186_s12967_020_02380_2
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-05-18
PublicationDateYYYYMMDD 2020-05-18
PublicationDate_xml – month: 05
  year: 2020
  text: 2020-05-18
  day: 18
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Journal of translational medicine
PublicationTitleAlternate J Transl Med
PublicationYear 2020
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References AC Court (2380_CR88) 2020; 21
O DelaRosa (2380_CR48) 2012; 21
AT Obi (2380_CR228) 2019; 7
VM Ranieri (2380_CR18) 2012; 307
KE Hostettler (2380_CR91) 2017; 12
D Perlee (2380_CR174) 2018; 36
A Krasnodembskaya (2380_CR3) 2010; 28
B Amorin (2380_CR199) 2014; 27
SW Ryter (2380_CR102) 2009; 5
BMA Antebi (2380_CR201) 2018; 84
BNA Gutbier (2380_CR235) 2018; 198
Z Leng (2380_CR9) 2020; 11
L Liao (2380_CR227) 2017; 7
I Martínez-González (2380_CR144) 2013; 49
JM Alvaro-Gracia (2380_CR171) 2017; 76
JD Silva (2380_CR151) 2019; 2019
SM Melief (2380_CR133) 2013; 2
YX Mao (2380_CR73) 2015; 33
CA Kindig (2380_CR158) 2001; 91
O Adams (2380_CR84) 2004; 78
S Barlow (2380_CR38) 2008; 17
E Ivanova-Todorova (2380_CR132) 2009; 126
M Spriet (2380_CR45) 2015; 56
KW Hinchcliff (2380_CR157) 2015; 29
AI Caplan (2380_CR29) 1991; 9
F Li (2380_CR81) 2017; 30
M Mohammadian (2380_CR94) 2016; 194
JA Ankrum (2380_CR47) 2014; 32
DK Sung (2380_CR77) 2016; 18
S Wei (2380_CR198) 2019; 28
G Rigotti (2380_CR164) 2007; 119
O Fernández (2380_CR195) 2018; 13
J Liang (2380_CR207) 2012; 61
X Zou (2380_CR100) 2014; 5
MA Matthay (2380_CR229) 2019; 7
RM Baron (2380_CR17) 2016; 5
F Derksen (2380_CR156) 2011; 33
S Aguilar (2380_CR93) 2009; 4
L Zimmerlin (2380_CR209) 2011; 17
M Jurado (2380_CR200) 2017; 19
S Tripathi (2380_CR82) 2013; 94
AGA Duggal (2380_CR27) 2015; 81
M Kabat (2380_CR167) 2020; 9
RH Lee (2380_CR42) 2009; 5
H Loy (2380_CR108) 2019; 219
DO Traktuev (2380_CR165) 2008; 102
T Chen (2380_CR219) 2020; 368
L Gao (2380_CR61) 2016; 34
Y Zhu (2380_CR180) 2009; 324
S Hashmi (2380_CR177) 2016; 3
DJ Prockop (2380_CR54) 2017; 19
LA McIntyre (2380_CR139) 2016; 11
S Beyth (2380_CR58) 2005; 105
CM Peeters (2380_CR169) 2013; 21
CJZF Luo (2380_CR150) 2014; 41
CS Calfee (2380_CR233) 2012; 40
SM Shalaby (2380_CR136) 2014; 16
ME Morris (2380_CR163) 2015; 4
S Gennai (2380_CR110) 2015; 15
S Asmussen (2380_CR152) 2014; 69
M Najar (2380_CR60) 2010; 16
MM Lalu (2380_CR168) 2012; 7
CR Harrell (2380_CR2) 2019; 2019
M Di Nicola (2380_CR57) 2002; 99
TG Shah (2380_CR118) 2019; 8
YG Zhu (2380_CR111) 2014; 32
LB Ware (2380_CR15) 2000; 342
YA Tsai (2380_CR176) 2017; 26
C Huang (2380_CR6) 2020; 395
KA Kwak (2380_CR193) 2018; 2018
D Jiang (2380_CR63) 2016; 34
2380_CR13
MV Jackson (2380_CR101) 2016; 34
L Zhang (2380_CR72) 2019; 25
A Monsel (2380_CR112) 2015; 192
J Buschmann (2380_CR36) 2013; 15
I Martin-Padura (2380_CR210) 2012; 72
A Agrawal (2380_CR232) 2013; 187
JW Lee (2380_CR49) 2009; 9
A Torres Crigna (2380_CR188) 2018; 5
SM Parikh (2380_CR237) 2017; 24
L Pedrazza (2380_CR75) 2017; 232
UM Fischer (2380_CR43) 2009; 18
EK Birks (2380_CR155) 2002; 34
TD Henry (2380_CR205) 2017; 89
Y Shi (2380_CR1) 2012; 33
SH Mei (2380_CR116) 2007; 4
2380_CR154
2380_CR153
Y Moodley (2380_CR97) 2009; 175
JD Silva (2380_CR148) 2018; 46
LM Curtis (2380_CR215) 2014; 49
AR Tonelli (2380_CR26) 2014; 40
SJ Lee (2380_CR103) 2011; 183
BA Christy (2380_CR221) 2017; 83
E Kolaczkowska (2380_CR23) 2013; 13
K Obojes (2380_CR86) 2005; 79
MS Herridge (2380_CR19) 2011; 364
MA Antunes (2380_CR146) 2014; 15
K Comella (2380_CR203) 2016; 14
JL Mumaw (2380_CR67) 2015; 103
I Bochev (2380_CR131) 2008; 32
2380_CR240
S Oliphant (2380_CR87) 2015; 28
2380_CR242
K Gupta (2380_CR70) 2013; 4
2380_CR243
L Mazini (2380_CR33) 2019; 20
C Qin (2380_CR56) 2020
X Qian (2380_CR89) 2016; 5
W Wagner (2380_CR37) 2005; 33
F Braza (2380_CR64) 2016; 34
N Gupta (2380_CR140) 2007; 179
J Behnke (2380_CR92) 2020; 9
JW Lee (2380_CR109) 2009; 106
P Zhou (2380_CR11) 2020; 579
M Manohar (2380_CR159) 1996; 81
AV Vanikar (2380_CR206) 2014; 36
2380_CR238
F Zhou (2380_CR217) 2020; 395
S Arai (2380_CR214) 2015; 21
NM Toyserkani (2380_CR202) 2017; 6
S Ghanta (2380_CR105) 2017; 56
D Dufrane (2380_CR34) 2017; 26
V Bhandari (2380_CR236) 2006; 12
J Kastrup (2380_CR172) 2017; 6
R Lu (2380_CR10) 2020; 395
G Moll (2380_CR222) 2019; 25
KC Lin (2380_CR187) 2016; 216
M Donahoe (2380_CR16) 2011; 1
CC dos Santos (2380_CR99) 2012; 181
MG Amer (2380_CR185) 2018; 654
SF de Witte (2380_CR65) 2018; 36
N Gupta (2380_CR78) 2012; 67
S Sullivan (2380_CR160) 2015; 31
M Hayes (2380_CR142) 2015; 3
G Moll (2380_CR226) 2015; 24
D Kuah (2380_CR173) 2018; 16
TJ Morrison (2380_CR123) 2017; 196
MJ George (2380_CR224) 2018; 7
BG Rowan (2380_CR211) 2014; 9
X Wu (2380_CR117) 2018; 370
Y Song (2380_CR189) 2018; 13
M Hayes (2380_CR137) 2015; 122
A Gazdhar (2380_CR96) 2014; 5
C Guerin (2380_CR24) 2013; 368
SH Mei (2380_CR79) 2010; 182
G Zheng (2380_CR230) 2014; 15
Z Xu (2380_CR14) 2020; 8
DS Karbing (2380_CR20) 2007; 11
JG Wilson (2380_CR55) 2015; 3
AJ Friedenstein (2380_CR28) 1968; 6
E Eggenhofer (2380_CR44) 2012; 3
L Papazian (2380_CR25) 2010; 363
R Mao (2380_CR83) 2011; 85
G Moll (2380_CR223) 2012; 30
DJ Prockop (2380_CR53) 2012; 20
L Wang (2380_CR216) 2018; 97
SCC Gopal (2380_CR184) 2015; 15
M Rojas (2380_CR134) 2005; 33
S Bruno (2380_CR98) 2009; 20
B Puissant (2380_CR130) 2005; 129
FF Cruz (2380_CR147) 2016; 16
JL Alio Del Barrio (2380_CR90) 2015; 132C
L Chen (2380_CR121) 2017; 6
F De Francesco (2380_CR183) 2016; 17
SKY Shin (2380_CR145) 2013; 10
N Shologu (2380_CR138) 2018; 19
GF Curley (2380_CR141) 2012; 67
M Levi (2380_CR220) 2017; 149
G Ertas (2380_CR128) 2012; 2012
2380_CR178
EC Perin (2380_CR204) 2014; 168
LB Ware (2380_CR106) 2001; 163
D Perlee (2380_CR225) 2019; 10
K Ni (2380_CR95) 2018; 58
ZD Liang (2380_CR71) 2013; 11
K Waked (2380_CR212) 2017; 31
PV Michelotto Jr (2380_CR162) 2011; 190
M Levi (2380_CR218) 2010; 36
R Izadpanah (2380_CR127) 2006; 99
A Leyendecker Jr (2380_CR62) 2018; 9
MS Zinter (2380_CR234) 2016; 310
D Wang (2380_CR7) 2020
Y Liu (2380_CR239) 2020
S Horie (2380_CR22) 2018; 10
Q Li (2380_CR8) 2020; 382
XD Tang (2380_CR124) 2017; 35
J Park (2380_CR120) 2019; 74
B Usunier (2380_CR166) 2014; 2014
AK Shetty (2380_CR241) 2020; 11
B Xiang (2380_CR114) 2017; 18
K Schenke-Layland (2380_CR179) 2009; 153
A Krasnodembskaya (2380_CR80) 2012; 302
X Fang (2380_CR113) 2010; 285
J Kim (2380_CR129) 2007; 20
SL Sullivan (2380_CR161) 2015; 47
J Li (2380_CR104) 2015; 19
F Paduano (2380_CR192) 2017; 18
AJ Nixon (2380_CR41) 2008; 69
A Monsel (2380_CR46) 2014; 121
TA Moseley (2380_CR85) 2006; 118
IA White (2380_CR182) 2016; 1416
J Freitag (2380_CR190) 2019; 12
CL Chang (2380_CR125) 2018; 10
P Connick (2380_CR52) 2012; 11
M Hoffmann (2380_CR12) 2020
H Takahashi (2380_CR186) 2019; 8
EM Horwitz (2380_CR30) 2005; 7
AC Bowles (2380_CR194) 2018; 15
MC Chan (2380_CR115) 2016; 113
MJ Park (2380_CR197) 2015; 24
KT Hughes (2380_CR21) 2017; 141
LA Huppert (2380_CR107) 2017; 8
M Hosseini (2380_CR5) 2015; 21
P Gao (2380_CR69) 2013; 31
A Guercio (2380_CR39) 2012; 36
F Sônego (2380_CR68) 2016; 7
J Xu (2380_CR135) 2007; 293
OE Simonson (2380_CR231) 2015; 4
G Zheng (2380_CR74) 2018; 374
M Khatri (2380_CR4) 2018; 9
JW Li (2380_CR149) 2015; 19
CM Miao (2380_CR76) 2016; 179
E Gonzalez-Rey (2380_CR66) 2009; 58
S Kern (2380_CR126) 2006; 24
J Freitag (2380_CR175) 2019; 14
BA Tompkins (2380_CR208) 2017; 72
AI Caplan (2380_CR32) 2017; 6
TSJ Maron-Gutierrez (2380_CR143) 2013; 41
M McVey (2380_CR119) 2012; 303
K Lai (2380_CR196) 2011; 43
JC Ra (2380_CR213) 2011; 20
J Panés (2380_CR170) 2016; 388
S Glennie (2380_CR59) 2005; 105
X Bai (2380_CR181) 2010; 31
R Harman (2380_CR40) 2016; 3
MN Islam (2380_CR122) 2012; 18
M Dominici (2380_CR31) 2006; 8
Y Zhou (2380_CR51) 2019; 8
B Strem (2380_CR35) 2005; 54
MM Duffy (2380_CR50) 2011; 2
S Ciuffi (2380_CR191) 2017; 14
References_xml – volume: 25
  start-page: 149
  issue: 2
  year: 2019
  ident: 2380_CR222
  publication-title: Trends Mol Med.
  doi: 10.1016/j.molmed.2018.12.006
– volume: 16
  start-page: 3537
  issue: 11
  year: 2010
  ident: 2380_CR60
  publication-title: Tissue Eng Part A
  doi: 10.1089/ten.tea.2010.0159
– volume: 84
  start-page: 183
  issue: 1
  year: 2018
  ident: 2380_CR201
  publication-title: J Trauma Acute Care Surg.
  doi: 10.1097/TA.0000000000001713
– volume: 6
  start-page: 230
  issue: 2
  year: 1968
  ident: 2380_CR28
  publication-title: Transplantation
  doi: 10.1097/00007890-196803000-00009
– volume: 18
  start-page: 689
  issue: 4
  year: 2017
  ident: 2380_CR114
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms18040689
– volume: 5
  start-page: 179
  year: 2018
  ident: 2380_CR188
  publication-title: Front Med.
  doi: 10.3389/fmed.2018.00179
– volume: 129
  start-page: 118
  issue: 1
  year: 2005
  ident: 2380_CR130
  publication-title: Br J Haematol
  doi: 10.1111/j.1365-2141.2005.05409.x
– volume: 24
  start-page: 2367
  issue: 11
  year: 2015
  ident: 2380_CR197
  publication-title: Cell Transplant
  doi: 10.3727/096368914X685645
– volume: 21
  start-page: 1537
  issue: 9
  year: 2015
  ident: 2380_CR5
  publication-title: Biol Blood Marrow Transplant
  doi: 10.1016/j.bbmt.2015.05.008
– volume: 25
  start-page: 2623
  year: 2019
  ident: 2380_CR72
  publication-title: Med Sci Monit
  doi: 10.12659/MSM.915804
– volume: 6
  start-page: 1445
  issue: 6
  year: 2017
  ident: 2380_CR32
  publication-title: Stem cells Transl Med.
  doi: 10.1002/sctm.17-0051
– volume: 105
  start-page: 2214
  issue: 5
  year: 2005
  ident: 2380_CR58
  publication-title: Blood
  doi: 10.1182/blood-2004-07-2921
– volume: 7
  start-page: e47559
  issue: 10
  year: 2012
  ident: 2380_CR168
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0047559
– volume: 18
  start-page: 2140
  issue: 10
  year: 2017
  ident: 2380_CR192
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms18102140
– volume: 16
  start-page: 1353
  issue: 11
  year: 2016
  ident: 2380_CR147
  publication-title: Expert Opin Biol Ther.
  doi: 10.1080/14712598.2016.1218845
– volume: 79
  start-page: 7768
  issue: 12
  year: 2005
  ident: 2380_CR86
  publication-title: J Virol
  doi: 10.1128/JVI.79.12.7768-7776.2005
– volume: 8
  start-page: 1025
  issue: 7
  year: 2019
  ident: 2380_CR51
  publication-title: J Clin Med.
  doi: 10.3390/jcm8071025
– volume: 388
  start-page: 1281
  issue: 10051
  year: 2016
  ident: 2380_CR170
  publication-title: Lancet
  doi: 10.1016/S0140-6736(16)31203-X
– volume: 49
  start-page: 1513
  issue: 12
  year: 2014
  ident: 2380_CR215
  publication-title: Bone Marrow Transplant
  doi: 10.1038/bmt.2014.188
– volume: 132C
  start-page: 91
  year: 2015
  ident: 2380_CR90
  publication-title: Exp Eye Res
  doi: 10.1016/j.exer.2015.01.020
– volume: 5
  start-page: 725
  issue: F1000 Faculty R
  year: 2016
  ident: 2380_CR17
  publication-title: F1000Res
  doi: 10.12688/f1000research.7646.1
– volume: 28
  start-page: 580
  issue: 10
  year: 2015
  ident: 2380_CR87
  publication-title: Viral Immunol
  doi: 10.1089/vim.2015.0039
– volume: 28
  start-page: 199
  issue: 2
  year: 2019
  ident: 2380_CR198
  publication-title: Lupus.
  doi: 10.1177/0961203318819131
– volume: 26
  start-page: 1496
  issue: 9
  year: 2017
  ident: 2380_CR34
  publication-title: Cell Transplant
  doi: 10.1177/0963689717721203
– volume: 15
  start-page: 77
  issue: 1
  year: 2018
  ident: 2380_CR194
  publication-title: J Neuroinflamm.
  doi: 10.1186/s12974-018-1099-3
– volume: 302
  start-page: L1003
  issue: 10
  year: 2012
  ident: 2380_CR80
  publication-title: Am J Physiol Lung Cell Mol Physiol
  doi: 10.1152/ajplung.00180.2011
– volume: 16
  start-page: 49
  issue: 1
  year: 2018
  ident: 2380_CR173
  publication-title: J Transl Med.
  doi: 10.1186/s12967-018-1420-z
– volume: 368
  start-page: m1091
  year: 2020
  ident: 2380_CR219
  publication-title: BMJ
  doi: 10.1136/bmj.m1091
– year: 2020
  ident: 2380_CR12
  publication-title: bioRxiv
  doi: 10.1101/2020.01.31.929042
– volume: 183
  start-page: 649
  issue: 5
  year: 2011
  ident: 2380_CR103
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201005-0746OC
– volume: 49
  start-page: 552
  issue: 4
  year: 2013
  ident: 2380_CR144
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/rcmb.2012-0406OC
– volume: 182
  start-page: 1047
  issue: 8
  year: 2010
  ident: 2380_CR79
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201001-0010OC
– volume: 198
  start-page: 220
  year: 2018
  ident: 2380_CR235
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201708-1733OC
– volume: 118
  start-page: 121S
  issue: 3 Suppl
  year: 2006
  ident: 2380_CR85
  publication-title: Plast Reconstr Surg
  doi: 10.1097/01.prs.0000234609.74811.2e
– volume: 69
  start-page: 928
  issue: 7
  year: 2008
  ident: 2380_CR41
  publication-title: Am J Vet Res
  doi: 10.2460/ajvr.69.7.928
– volume: 175
  start-page: 303
  issue: 1
  year: 2009
  ident: 2380_CR97
  publication-title: Am J Pathol
  doi: 10.2353/ajpath.2009.080629
– volume: 2012
  start-page: 105698
  year: 2012
  ident: 2380_CR128
  publication-title: Sci World J
  doi: 10.1100/2012/105698
– volume: 46
  start-page: e132
  issue: 2
  year: 2018
  ident: 2380_CR148
  publication-title: Crit Care Med
  doi: 10.1097/CCM.0000000000002833
– volume: 9
  start-page: 641
  issue: 5
  year: 1991
  ident: 2380_CR29
  publication-title: J Orthop Res.
  doi: 10.1002/jor.1100090504
– volume: 654
  start-page: 87
  year: 2018
  ident: 2380_CR185
  publication-title: Gene
  doi: 10.1016/j.gene.2018.02.008
– volume: 97
  start-page: 1941
  issue: 10
  year: 2018
  ident: 2380_CR216
  publication-title: Ann Hematol
  doi: 10.1007/s00277-018-3384-8
– volume: 67
  start-page: 496
  issue: 6
  year: 2012
  ident: 2380_CR141
  publication-title: Thorax
  doi: 10.1136/thoraxjnl-2011-201059
– volume: 40
  start-page: 1731
  issue: 6
  year: 2012
  ident: 2380_CR233
  publication-title: Crit Care Med
  doi: 10.1097/CCM.0b013e3182451c87
– volume: 19
  start-page: 2368
  issue: 13
  year: 2015
  ident: 2380_CR149
  publication-title: Eur Rev Med Pharmacol Sci.
– volume: 11
  start-page: e0147170
  issue: 1
  year: 2016
  ident: 2380_CR139
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0147170
– volume: 187
  start-page: 736
  issue: 7
  year: 2013
  ident: 2380_CR232
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201208-1460OC
– year: 2020
  ident: 2380_CR56
  publication-title: China. Clin Infect Dis.
  doi: 10.1093/cid/ciaa248
– volume: 31
  start-page: 1313
  issue: 6
  year: 2013
  ident: 2380_CR69
  publication-title: Int J Mol Med
  doi: 10.3892/ijmm.2013.1328
– volume: 34
  start-page: 2393
  issue: 9
  year: 2016
  ident: 2380_CR63
  publication-title: Stem Cells.
  doi: 10.1002/stem.2417
– volume: 19
  start-page: 1
  issue: 1
  year: 2017
  ident: 2380_CR54
  publication-title: Cytotherapy.
  doi: 10.1016/j.jcyt.2016.09.008
– volume: 363
  start-page: 1107
  issue: 12
  year: 2010
  ident: 2380_CR25
  publication-title: N Engl J Med.
  doi: 10.1056/NEJMoa1005372
– volume: 194
  start-page: 777
  issue: 5
  year: 2016
  ident: 2380_CR94
  publication-title: Lung
  doi: 10.1007/s00408-016-9884-1
– volume: 293
  start-page: L131
  issue: 1
  year: 2007
  ident: 2380_CR135
  publication-title: Am J Physiol Lung Cell Mol Physiol
  doi: 10.1152/ajplung.00431.2006
– volume: 40
  start-page: 769
  issue: 6
  year: 2014
  ident: 2380_CR26
  publication-title: Intensive Care Med
  doi: 10.1007/s00134-014-3272-1
– volume: 106
  start-page: 16357
  issue: 38
  year: 2009
  ident: 2380_CR109
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0907996106
– volume: 21
  start-page: 266
  issue: 2
  year: 2015
  ident: 2380_CR214
  publication-title: Biol Blood Marrow Transplant
  doi: 10.1016/j.bbmt.2014.10.021
– volume: 33
  start-page: 145
  issue: 2
  year: 2005
  ident: 2380_CR134
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/rcmb.2004-0330OC
– volume: 219
  start-page: 186
  issue: 2
  year: 2019
  ident: 2380_CR108
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jiy478
– volume: 4
  start-page: 19
  issue: 1
  year: 2013
  ident: 2380_CR70
  publication-title: Stem Cell Res Therapy.
  doi: 10.1186/scrt167
– volume: 34
  start-page: 375
  year: 2002
  ident: 2380_CR155
  publication-title: Equine Vet J Suppl.
  doi: 10.1111/j.2042-3306.2002.tb05451.x
– volume: 36
  start-page: 1778
  issue: 11
  year: 2018
  ident: 2380_CR174
  publication-title: Stem Cells.
  doi: 10.1002/stem.2891
– volume: 15
  start-page: 2404
  issue: 9
  year: 2015
  ident: 2380_CR110
  publication-title: Am J Transplant
  doi: 10.1111/ajt.13271
– volume: 61
  start-page: 468
  issue: 3
  year: 2012
  ident: 2380_CR207
  publication-title: Gut
  doi: 10.1136/gutjnl-2011-300083
– volume: 18
  start-page: 759
  issue: 5
  year: 2012
  ident: 2380_CR122
  publication-title: Nat Med
  doi: 10.1038/nm.2736
– volume: 9
  start-page: e89595
  issue: 2
  year: 2014
  ident: 2380_CR211
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0089595
– volume: 9
  start-page: 2056
  year: 2018
  ident: 2380_CR62
  publication-title: Front Immunol.
  doi: 10.3389/fimmu.2018.02056
– volume: 54
  start-page: 132
  issue: 3
  year: 2005
  ident: 2380_CR35
  publication-title: Keio J Med
  doi: 10.2302/kjm.54.132
– volume: 7
  start-page: 106
  issue: 1
  year: 2017
  ident: 2380_CR227
  publication-title: Theranostics.
  doi: 10.7150/thno.16911
– volume: 285
  start-page: 26211
  issue: 34
  year: 2010
  ident: 2380_CR113
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.119917
– volume: 7
  start-page: 155
  year: 2016
  ident: 2380_CR68
  publication-title: Front Immunol.
  doi: 10.3389/fimmu.2016.00155
– volume: 17
  start-page: 889
  issue: 9
  year: 2016
  ident: 2380_CR183
  publication-title: Cancer Biol Ther
  doi: 10.1080/15384047.2016.1210741
– ident: 2380_CR13
– volume: 374
  start-page: 1
  issue: 1
  year: 2018
  ident: 2380_CR74
  publication-title: Cell Tissue Res
  doi: 10.1007/s00441-018-2871-5
– ident: 2380_CR242
– volume: 342
  start-page: 1334
  issue: 18
  year: 2000
  ident: 2380_CR15
  publication-title: N Engl J Med.
  doi: 10.1056/NEJM200005043421806
– volume: 35
  start-page: 1849
  issue: 7
  year: 2017
  ident: 2380_CR124
  publication-title: Stem Cells.
  doi: 10.1002/stem.2619
– volume: 31
  start-page: 187
  issue: 1
  year: 2015
  ident: 2380_CR160
  publication-title: Vet Clin North Am Equine Pract
  doi: 10.1016/j.cveq.2014.11.011
– volume: 15
  start-page: 41
  year: 2015
  ident: 2380_CR184
  publication-title: Clin Exp Med
  doi: 10.1007/s10238-013-0266-1
– volume: 3
  start-page: 29
  issue: 1
  year: 2015
  ident: 2380_CR142
  publication-title: Intensive Care Med Exp.
  doi: 10.1186/s40635-015-0065-y
– volume: 15
  start-page: 118
  issue: 1
  year: 2014
  ident: 2380_CR146
  publication-title: Respir Res
  doi: 10.1186/s12931-014-0118-x
– volume: 76
  start-page: 196
  issue: 1
  year: 2017
  ident: 2380_CR171
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2015-208918
– volume: 103
  start-page: 60
  year: 2015
  ident: 2380_CR67
  publication-title: Res Vet Sci
  doi: 10.1016/j.rvsc.2015.09.010
– volume: 163
  start-page: 1376
  issue: 6
  year: 2001
  ident: 2380_CR106
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.163.6.2004035
– volume: 4
  start-page: e8013
  issue: 11
  year: 2009
  ident: 2380_CR93
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0008013
– volume: 58
  start-page: 929
  issue: 7
  year: 2009
  ident: 2380_CR66
  publication-title: Gut
  doi: 10.1136/gut.2008.168534
– volume: 30
  start-page: 542
  issue: 7
  year: 2017
  ident: 2380_CR81
  publication-title: Viral Immunol
  doi: 10.1089/vim.2016.0140
– volume: 192
  start-page: 324
  issue: 3
  year: 2015
  ident: 2380_CR112
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201410-1765OC
– volume: 113
  start-page: 3621
  issue: 13
  year: 2016
  ident: 2380_CR115
  publication-title: Proc Nat Acad Sci USA.
  doi: 10.1073/pnas.1601911113
– volume: 5
  start-page: 40
  issue: 2
  year: 2014
  ident: 2380_CR100
  publication-title: Stem Cell Res Therapy.
  doi: 10.1186/scrt428
– year: 2020
  ident: 2380_CR239
  publication-title: medRxiv.
  doi: 10.1101/2020.02.17.20024166
– ident: 2380_CR240
  doi: 10.1097/MD.0000000000021429
– volume: 34
  start-page: 2843
  issue: 24
  year: 2016
  ident: 2380_CR61
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2015.65.3642
– volume: 3
  start-page: 24
  issue: 1
  year: 2015
  ident: 2380_CR55
  publication-title: Lancet Respir Med.
  doi: 10.1016/S2213-2600(14)70291-7
– volume: 10
  start-page: 8
  year: 2013
  ident: 2380_CR145
  publication-title: Int J Med Sci
  doi: 10.7150/ijms.5385
– volume: 19
  start-page: 2996
  issue: 10
  year: 2018
  ident: 2380_CR138
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms19102996
– ident: 2380_CR154
– volume: 105
  start-page: 2821
  issue: 7
  year: 2005
  ident: 2380_CR59
  publication-title: Blood
  doi: 10.1182/blood-2004-09-3696
– volume-title: Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan
  year: 2020
  ident: 2380_CR7
  doi: 10.1001/jama.2020.1585
– volume: 153
  start-page: 217
  issue: 2
  year: 2009
  ident: 2380_CR179
  publication-title: J Surg Res.
  doi: 10.1016/j.jss.2008.03.019
– volume: 141
  start-page: 916
  issue: 7
  year: 2017
  ident: 2380_CR21
  publication-title: Arch Pathol Lab Med
  doi: 10.5858/arpa.2016-0342-RA
– volume: 7
  start-page: 393
  issue: 5
  year: 2005
  ident: 2380_CR30
  publication-title: Cytotherapy.
  doi: 10.1080/14653240500319234
– volume: 34
  start-page: 1836
  issue: 7
  year: 2016
  ident: 2380_CR64
  publication-title: Stem Cells.
  doi: 10.1002/stem.2344
– volume: 20
  start-page: 867
  year: 2007
  ident: 2380_CR129
  publication-title: Cell Physiol Biochem
  doi: 10.1159/000110447
– volume: 12
  start-page: e227865
  issue: 2
  year: 2019
  ident: 2380_CR190
  publication-title: BMJ Case Rep.
  doi: 10.1136/bcr-2018-227865
– volume: 126
  start-page: 37
  issue: 1–2
  year: 2009
  ident: 2380_CR132
  publication-title: Immunol Lett
  doi: 10.1016/j.imlet.2009.07.010
– volume: 56
  start-page: 300
  issue: 3
  year: 2017
  ident: 2380_CR105
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/rcmb.2016-0061OC
– volume: 33
  start-page: 136
  issue: 3
  year: 2012
  ident: 2380_CR1
  publication-title: Trends Immunol
  doi: 10.1016/j.it.2011.11.004
– volume: 36
  start-page: 367
  issue: 4
  year: 2010
  ident: 2380_CR218
  publication-title: Semin Thromb Hemost
  doi: 10.1055/s-0030-1254046
– volume: 8
  start-page: 315
  issue: 4
  year: 2006
  ident: 2380_CR31
  publication-title: Cytotherapy.
  doi: 10.1080/14653240600855905
– volume: 190
  start-page: e3
  issue: 2
  year: 2011
  ident: 2380_CR162
  publication-title: Vet J.
  doi: 10.1016/j.tvjl.2010.08.009
– volume: 8
  start-page: 371
  year: 2017
  ident: 2380_CR107
  publication-title: Front Immunol.
  doi: 10.3389/fimmu.2017.00371
– volume: 6
  start-page: 272
  issue: 1
  year: 2017
  ident: 2380_CR121
  publication-title: Stem Cells Transl Med.
  doi: 10.5966/sctm.2015-0265
– volume: 119
  start-page: 1409
  issue: 5
  year: 2007
  ident: 2380_CR164
  publication-title: Plast Reconstruct Surg.
  doi: 10.1097/01.prs.0000256047.47909.71
– volume: 94
  start-page: 40
  issue: Pt 1
  year: 2013
  ident: 2380_CR82
  publication-title: J Gen Virol
  doi: 10.1099/vir.0.045013-0
– volume: 36
  start-page: 1376
  issue: 9
  year: 2014
  ident: 2380_CR206
  publication-title: Ren Fail
  doi: 10.3109/0886022X.2014.950931
– volume: 395
  start-page: 497
  issue: 10223
  year: 2020
  ident: 2380_CR6
  publication-title: Lancet.
  doi: 10.1016/S0140-6736(20)30183-5
– volume: 74
  start-page: 43
  issue: 1
  year: 2019
  ident: 2380_CR120
  publication-title: Thorax
  doi: 10.1136/thoraxjnl-2018-211576
– volume: 14
  start-page: 158
  issue: 1
  year: 2016
  ident: 2380_CR203
  publication-title: J Transl Med.
  doi: 10.1186/s12967-016-0918-5
– volume: 216
  start-page: 173
  year: 2016
  ident: 2380_CR187
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2016.04.061
– volume: 56
  start-page: 327
  issue: 3
  year: 2015
  ident: 2380_CR45
  publication-title: Vet Radiol Ultrasound.
  doi: 10.1111/vru.12243
– volume: 370
  start-page: 13
  issue: 1
  year: 2018
  ident: 2380_CR117
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2018.06.003
– volume: 33
  start-page: 1402
  issue: 11
  year: 2005
  ident: 2380_CR37
  publication-title: Exp Hematol
  doi: 10.1016/j.exphem.2005.07.003
– volume: 179
  start-page: 102
  year: 2016
  ident: 2380_CR76
  publication-title: Immunol Lett
  doi: 10.1016/j.imlet.2016.09.009
– volume: 2
  start-page: 34
  issue: 4
  year: 2011
  ident: 2380_CR50
  publication-title: Stem Cell Res Therapy.
  doi: 10.1186/scrt75
– ident: 2380_CR178
  doi: 10.1136/lupus-2018-lsm.76
– volume: 9
  start-page: 682
  issue: 3
  year: 2020
  ident: 2380_CR92
  publication-title: J Clin Med.
  doi: 10.3390/jcm9030682
– volume: 20
  start-page: 1053
  issue: 5
  year: 2009
  ident: 2380_CR98
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2008070798
– volume: 11
  start-page: 179
  issue: 1
  year: 2013
  ident: 2380_CR71
  publication-title: J Transl Med.
  doi: 10.1186/1479-5876-11-179
– volume: 12
  start-page: e0181946
  issue: 8
  year: 2017
  ident: 2380_CR91
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0181946
– volume: 6
  start-page: 1963
  issue: 11
  year: 2017
  ident: 2380_CR172
  publication-title: Stem Cells Transl Med.
  doi: 10.1002/sctm.17-0040
– volume: 81
  start-page: 567
  year: 2015
  ident: 2380_CR27
  publication-title: Minera Anest
– volume: 14
  start-page: 217
  issue: 2
  year: 2017
  ident: 2380_CR191
  publication-title: Clin Cases Miner Bone Metab.
  doi: 10.11138/ccmbm/2017.14.1.217
– volume: 307
  start-page: 2526
  issue: 23
  year: 2012
  ident: 2380_CR18
  publication-title: JAMA
– volume: 2019
  start-page: 4236973
  year: 2019
  ident: 2380_CR2
  publication-title: Stem cells international.
– volume: 72
  start-page: 325
  issue: 1
  year: 2012
  ident: 2380_CR210
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-11-1739
– volume: 9
  start-page: 17
  issue: 1
  year: 2018
  ident: 2380_CR4
  publication-title: Stem Cell Res Therapy.
  doi: 10.1186/s13287-018-0774-8
– volume: 20
  start-page: 14
  issue: 1
  year: 2012
  ident: 2380_CR53
  publication-title: Mol Therapy.
  doi: 10.1038/mt.2011.211
– volume: 33
  start-page: E6
  issue: 4
  year: 2011
  ident: 2380_CR156
  publication-title: Compendium.
– volume: 11
  start-page: R118
  issue: 6
  year: 2007
  ident: 2380_CR20
  publication-title: Crit Care
  doi: 10.1186/cc6174
– volume: 24
  start-page: 2269
  issue: 19
  year: 2015
  ident: 2380_CR226
  publication-title: Stem Cells and Dev.
  doi: 10.1089/scd.2015.0120
– volume: 8
  start-page: 420
  issue: 4
  year: 2020
  ident: 2380_CR14
  publication-title: Lancet Respir Med.
  doi: 10.1016/S2213-2600(20)30076-X
– volume: 11
  start-page: 150
  issue: 2
  year: 2012
  ident: 2380_CR52
  publication-title: Lancet Neurol.
  doi: 10.1016/S1474-4422(11)70305-2
– volume: 58
  start-page: 684
  issue: 6
  year: 2018
  ident: 2380_CR95
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/rcmb.2017-0326OC
– volume: 85
  start-page: 1048
  issue: 2
  year: 2011
  ident: 2380_CR83
  publication-title: J Virol
  doi: 10.1128/JVI.01998-10
– volume: 2
  start-page: 455
  issue: 6
  year: 2013
  ident: 2380_CR133
  publication-title: Stem Cells Transl Med.
  doi: 10.5966/sctm.2012-0184
– volume: 310
  start-page: L224
  issue: 3
  year: 2016
  ident: 2380_CR234
  publication-title: Am J Physiol Lung Cell Mol Physiol
  doi: 10.1152/ajplung.00336.2015
– volume: 1
  start-page: 192
  issue: 2
  year: 2011
  ident: 2380_CR16
  publication-title: Pulm Circ.
  doi: 10.4103/2045-8932.83454
– ident: 2380_CR243
– volume: 91
  start-page: 1396
  issue: 3
  year: 2001
  ident: 2380_CR158
  publication-title: J Appl Physiol
  doi: 10.1152/jappl.2001.91.3.1396
– volume: 4
  start-page: 369
  issue: 4
  year: 2015
  ident: 2380_CR163
  publication-title: Stem Cells Transl Med.
  doi: 10.5966/sctm.2014-0252
– volume: 3
  start-page: 297
  year: 2012
  ident: 2380_CR44
  publication-title: Front Immunol.
  doi: 10.3389/fimmu.2012.00297
– volume: 7
  start-page: 317
  issue: 3
  year: 2019
  ident: 2380_CR228
  publication-title: J Vasc Surg Venous Lymph Disord.
  doi: 10.1016/j.jvsv.2018.08.010
– volume: 13
  start-page: 159
  issue: 3
  year: 2013
  ident: 2380_CR23
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri3399
– volume: 81
  start-page: 1589
  issue: 4
  year: 1996
  ident: 2380_CR159
  publication-title: J Appl Physiol
  doi: 10.1152/jappl.1996.81.4.1589
– volume: 121
  start-page: 1099
  issue: 5
  year: 2014
  ident: 2380_CR46
  publication-title: Anesthesiology
  doi: 10.1097/ALN.0000000000000446
– volume: 179
  start-page: 1855
  issue: 3
  year: 2007
  ident: 2380_CR140
  publication-title: J Immunol
  doi: 10.4049/jimmunol.179.3.1855
– volume: 78
  start-page: 2632
  issue: 5
  year: 2004
  ident: 2380_CR84
  publication-title: J Virol
  doi: 10.1128/JVI.78.5.2632-2636.2004
– volume: 43
  start-page: 805
  issue: 10
  year: 2011
  ident: 2380_CR196
  publication-title: Acta Biochim Biophys Sin
  doi: 10.1093/abbs/gmr077
– volume: 2014
  start-page: 340257
  year: 2014
  ident: 2380_CR166
  publication-title: Stem cells international.
  doi: 10.1155/2014/340257
– volume: 6
  start-page: 1786
  issue: 9
  year: 2017
  ident: 2380_CR202
  publication-title: Stem Cells Transl Med.
  doi: 10.1002/sctm.17-0031
– volume: 16
  start-page: 764
  issue: 6
  year: 2014
  ident: 2380_CR136
  publication-title: Cytotherapy.
  doi: 10.1016/j.jcyt.2013.12.006
– volume: 9
  start-page: 1259
  issue: 10
  year: 2009
  ident: 2380_CR49
  publication-title: Expert Opin Biol Therapy.
  doi: 10.1517/14712590903213651
– volume: 26
  start-page: 503
  issue: 3
  year: 2017
  ident: 2380_CR176
  publication-title: Cell Transplant
  doi: 10.3727/096368916X694373
– ident: 2380_CR238
– volume: 9
  start-page: 17
  issue: 1
  year: 2020
  ident: 2380_CR167
  publication-title: Stem Cells Transl Med.
  doi: 10.1002/sctm.19-0202
– volume: 89
  start-page: 169
  issue: 2
  year: 2017
  ident: 2380_CR205
  publication-title: Catheter Cardiovasc Interv.
  doi: 10.1002/ccd.26601
– volume: 395
  start-page: 565
  issue: 10224
  year: 2020
  ident: 2380_CR10
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30251-8
– volume: 28
  start-page: 2229
  issue: 12
  year: 2010
  ident: 2380_CR3
  publication-title: Stem Cells.
  doi: 10.1002/stem.544
– volume: 11
  start-page: 216
  year: 2020
  ident: 2380_CR9
  publication-title: Aging Dis.
  doi: 10.14336/AD.2020.0228
– volume: 102
  start-page: 77
  issue: 1
  year: 2008
  ident: 2380_CR165
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.107.159475
– volume: 5
  start-page: 1190
  issue: 9
  year: 2016
  ident: 2380_CR89
  publication-title: Stem cells translational medicine.
  doi: 10.5966/sctm.2015-0348
– volume: 3
  start-page: 81
  year: 2016
  ident: 2380_CR40
  publication-title: Front Vet Sci.
  doi: 10.3389/fvets.2016.00081
– volume: 149
  start-page: 38
  year: 2017
  ident: 2380_CR220
  publication-title: Thromb Res
  doi: 10.1016/j.thromres.2016.11.007
– volume: 579
  start-page: 270
  issue: 7798
  year: 2020
  ident: 2380_CR11
  publication-title: Nature
  doi: 10.1038/s41586-020-2012-7
– ident: 2380_CR153
– volume: 20
  start-page: 2523
  issue: 10
  year: 2019
  ident: 2380_CR33
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms20102523
– volume: 11
  start-page: 462
  issue: 2
  year: 2020
  ident: 2380_CR241
  publication-title: Aging and disease.
  doi: 10.14336/AD.2020.0301
– volume: 36
  start-page: 189
  issue: 2
  year: 2012
  ident: 2380_CR39
  publication-title: Cell Biol Int
  doi: 10.1042/CBI20110304
– volume: 15
  start-page: 39
  issue: 1
  year: 2014
  ident: 2380_CR230
  publication-title: Respir Res
  doi: 10.1186/1465-9921-15-39
– volume: 181
  start-page: 1681
  issue: 5
  year: 2012
  ident: 2380_CR99
  publication-title: Am J Pathol
  doi: 10.1016/j.ajpath.2012.08.009
– volume: 99
  start-page: 1285
  issue: 5
  year: 2006
  ident: 2380_CR127
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.20904
– volume: 5
  start-page: 235
  issue: 2
  year: 2009
  ident: 2380_CR102
  publication-title: Autophagy.
  doi: 10.4161/auto.5.2.7495
– volume: 36
  start-page: 602
  issue: 4
  year: 2018
  ident: 2380_CR65
  publication-title: Stem Cells.
  doi: 10.1002/stem.2779
– volume: 31
  start-page: 128
  year: 2017
  ident: 2380_CR212
  publication-title: Breast
  doi: 10.1016/j.breast.2016.11.001
– volume: 303
  start-page: L364
  issue: 5
  year: 2012
  ident: 2380_CR119
  publication-title: Am J Physiol Lung Cell Mol Physiol
  doi: 10.1152/ajplung.00354.2011
– volume: 13
  start-page: e0195891
  issue: 5
  year: 2018
  ident: 2380_CR195
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0195891
– volume: 7
  start-page: 731
  issue: 10
  year: 2018
  ident: 2380_CR224
  publication-title: Stem Cells Transl Med.
  doi: 10.1002/sctm.18-0015
– volume: 14
  start-page: 213
  issue: 3
  year: 2019
  ident: 2380_CR175
  publication-title: Regen Med.
  doi: 10.2217/rme-2018-0161
– volume: 3
  start-page: e45
  issue: 1
  year: 2016
  ident: 2380_CR177
  publication-title: Lancet Haematol.
  doi: 10.1016/S2352-3026(15)00224-0
– volume: 17
  start-page: 1095
  issue: 6
  year: 2008
  ident: 2380_CR38
  publication-title: Stem Cells Dev.
  doi: 10.1089/scd.2007.0154
– volume: 31
  start-page: 489
  issue: 4
  year: 2010
  ident: 2380_CR181
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehp568
– volume: 168
  start-page: 88
  issue: 1
  year: 2014
  ident: 2380_CR204
  publication-title: Am Heart J
  doi: 10.1016/j.ahj.2014.03.022
– volume: 1416
  start-page: 55
  year: 2016
  ident: 2380_CR182
  publication-title: Methods Mol Biol
  doi: 10.1007/978-1-4939-3584-0_4
– volume: 232
  start-page: 3552
  issue: 12
  year: 2017
  ident: 2380_CR75
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.25816
– volume: 19
  start-page: 927
  issue: 8
  year: 2017
  ident: 2380_CR200
  publication-title: Cytotherapy.
  doi: 10.1016/j.jcyt.2017.05.002
– volume: 32
  start-page: 384
  issue: 4
  year: 2008
  ident: 2380_CR131
  publication-title: Cell Biol Int
  doi: 10.1016/j.cellbi.2007.12.007
– volume: 21
  start-page: 1465
  issue: 10
  year: 2013
  ident: 2380_CR169
  publication-title: Osteoarthr Cartil OARS Osteoarthr Res Soc.
  doi: 10.1016/j.joca.2013.06.025
– volume: 2018
  start-page: 4197857
  year: 2018
  ident: 2380_CR193
  publication-title: Can J Gastroenterol Hepatol.
  doi: 10.1155/2018/4197857
– volume: 20
  start-page: 1297
  issue: 8
  year: 2011
  ident: 2380_CR213
  publication-title: Stem Cells Dev.
  doi: 10.1089/scd.2010.0466
– volume: 5
  start-page: 123
  issue: 6
  year: 2014
  ident: 2380_CR96
  publication-title: Stem Cell Res Therapy.
  doi: 10.1186/scrt513
– volume: 18
  start-page: 424
  issue: 3
  year: 2016
  ident: 2380_CR77
  publication-title: Cell Microbiol
  doi: 10.1111/cmi.12522
– volume: 382
  start-page: 1199
  year: 2020
  ident: 2380_CR8
  publication-title: N Engl J Med.
  doi: 10.1056/NEJMoa2001316
– volume: 41
  start-page: 123
  issue: 2
  year: 2014
  ident: 2380_CR150
  publication-title: Shock.
  doi: 10.1097/SHK.0000000000000080
– volume: 2019
  start-page: 8262849
  year: 2019
  ident: 2380_CR151
  publication-title: Stem cells international.
– volume: 83
  start-page: S164
  issue: 1 Suppl 1
  year: 2017
  ident: 2380_CR221
  publication-title: J Trauma Acute Care Surg.
  doi: 10.1097/TA.0000000000001485
– volume: 7
  start-page: 154
  issue: 2
  year: 2019
  ident: 2380_CR229
  publication-title: Lancet Respir Med.
  doi: 10.1016/S2213-2600(18)30418-1
– volume: 32
  start-page: 252
  issue: 3
  year: 2014
  ident: 2380_CR47
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.2816
– volume: 27
  start-page: 137
  issue: 4
  year: 2014
  ident: 2380_CR199
  publication-title: Hum Cell
  doi: 10.1007/s13577-014-0095-x
– volume: 34
  start-page: 2210
  issue: 8
  year: 2016
  ident: 2380_CR101
  publication-title: Stem Cells.
  doi: 10.1002/stem.2372
– volume: 368
  start-page: 2159
  issue: 23
  year: 2013
  ident: 2380_CR24
  publication-title: N Engl J Med.
  doi: 10.1056/NEJMoa1214103
– volume: 324
  start-page: 117
  issue: 1–2
  year: 2009
  ident: 2380_CR180
  publication-title: Mol Cell Biochem
– volume: 72
  start-page: 1513
  issue: 11
  year: 2017
  ident: 2380_CR208
  publication-title: J Gerontol A Biol Sci Med Sci
  doi: 10.1093/gerona/glx137
– volume: 8
  start-page: 25
  issue: 1
  year: 2019
  ident: 2380_CR118
  publication-title: Clin Transl Med.
  doi: 10.1186/s40169-019-0242-9
– volume: 32
  start-page: 116
  issue: 1
  year: 2014
  ident: 2380_CR111
  publication-title: Stem cells.
  doi: 10.1002/stem.1504
– volume: 17
  start-page: 93
  issue: 1–2
  year: 2011
  ident: 2380_CR209
  publication-title: Tissue Eng Part A
  doi: 10.1089/ten.tea.2010.0248
– volume: 19
  start-page: 2341
  issue: 10
  year: 2015
  ident: 2380_CR104
  publication-title: J Cell Mol Med
  doi: 10.1111/jcmm.12638
– volume: 21
  start-page: 1333
  issue: 8
  year: 2012
  ident: 2380_CR48
  publication-title: Stem cells and development.
  doi: 10.1089/scd.2011.0139
– volume: 30
  start-page: 1565
  issue: 7
  year: 2012
  ident: 2380_CR223
  publication-title: Stem Cells.
  doi: 10.1002/stem.1111
– volume: 395
  start-page: 1054
  issue: 10229
  year: 2020
  ident: 2380_CR217
  publication-title: The Lancet.
  doi: 10.1016/S0140-6736(20)30566-3
– volume: 15
  start-page: 1098
  issue: 9
  year: 2013
  ident: 2380_CR36
  publication-title: Cytotherapy.
  doi: 10.1016/j.jcyt.2013.04.009
– volume: 12
  start-page: 1286
  issue: 11
  year: 2006
  ident: 2380_CR236
  publication-title: Nat Med
  doi: 10.1038/nm1494
– volume: 33
  start-page: 2331
  issue: 7
  year: 2015
  ident: 2380_CR73
  publication-title: Stem Cells.
  doi: 10.1002/stem.1996
– volume: 41
  start-page: e319
  issue: 11
  year: 2013
  ident: 2380_CR143
  publication-title: Crit Care Med
  doi: 10.1097/CCM.0b013e31828a663e
– volume: 196
  start-page: 1275
  issue: 10
  year: 2017
  ident: 2380_CR123
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201701-0170OC
– volume: 99
  start-page: 3838
  issue: 10
  year: 2002
  ident: 2380_CR57
  publication-title: Blood
  doi: 10.1182/blood.V99.10.3838
– volume: 67
  start-page: 533
  issue: 6
  year: 2012
  ident: 2380_CR78
  publication-title: Thorax
  doi: 10.1136/thoraxjnl-2011-201176
– volume: 47
  start-page: 350
  issue: 3
  year: 2015
  ident: 2380_CR161
  publication-title: Equine Vet J.
  doi: 10.1111/evj.12263
– volume: 13
  start-page: 295
  issue: 3
  year: 2018
  ident: 2380_CR189
  publication-title: Regen Med.
  doi: 10.2217/rme-2017-0152
– volume: 364
  start-page: 1293
  issue: 14
  year: 2011
  ident: 2380_CR19
  publication-title: N Engl J Med.
  doi: 10.1056/NEJMoa1011802
– volume: 10
  start-page: 1053
  issue: 4
  year: 2018
  ident: 2380_CR125
  publication-title: Am J Transl Res.
– volume: 24
  start-page: 1294
  issue: 5
  year: 2006
  ident: 2380_CR126
  publication-title: Stem Cells.
  doi: 10.1634/stemcells.2005-0342
– volume: 10
  start-page: 286
  issue: 1
  year: 2019
  ident: 2380_CR225
  publication-title: Stem Cell Res Therapy.
  doi: 10.1186/s13287-019-1391-x
– volume: 4
  start-page: 1199
  issue: 10
  year: 2015
  ident: 2380_CR231
  publication-title: Stem Cells Transl Med.
  doi: 10.5966/sctm.2015-0021
– volume: 10
  start-page: 5607
  issue: 9
  year: 2018
  ident: 2380_CR22
  publication-title: J Thorac Dis.
  doi: 10.21037/jtd.2018.08.28
– volume: 69
  start-page: 819
  issue: 9
  year: 2014
  ident: 2380_CR152
  publication-title: Thorax
  doi: 10.1136/thoraxjnl-2013-204980
– volume: 24
  start-page: 432
  issue: 5
  year: 2017
  ident: 2380_CR237
  publication-title: Curr Opin Hematol
  doi: 10.1097/MOH.0000000000000361
– volume: 18
  start-page: 683
  issue: 5
  year: 2009
  ident: 2380_CR43
  publication-title: Stem Cells Dev.
  doi: 10.1089/scd.2008.0253
– volume: 8
  start-page: 249
  issue: 2
  year: 2019
  ident: 2380_CR186
  publication-title: J Clin Med.
  doi: 10.3390/jcm8020249
– volume: 21
  start-page: e48052
  issue: 2
  year: 2020
  ident: 2380_CR88
  publication-title: EMBO Rep
  doi: 10.15252/embr.201948052
– volume: 5
  start-page: 54
  issue: 1
  year: 2009
  ident: 2380_CR42
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2009.05.003
– volume: 29
  start-page: 743
  issue: 3
  year: 2015
  ident: 2380_CR157
  publication-title: J Vet Intern Med Am Coll Vet Int Med.
  doi: 10.1111/jvim.12593
– volume: 122
  start-page: 363
  issue: 2
  year: 2015
  ident: 2380_CR137
  publication-title: Anesthesiology
  doi: 10.1097/ALN.0000000000000545
– volume: 4
  start-page: e269
  issue: 9
  year: 2007
  ident: 2380_CR116
  publication-title: PLoS Med.
  doi: 10.1371/journal.pmed.0040269
SSID ssj0024549
Score 2.5485663
SecondaryResourceType review_article
Snippet In late 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan, capital city of Hubei province in China. Cases of SARS-CoV-2 infection quickly grew by several...
Abstract In late 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan, capital city of Hubei province in China. Cases of SARS-CoV-2 infection quickly grew...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 203
SubjectTerms Adipocytes
Alveoli
Animal models
Animals
ARDS
Betacoronavirus - physiology
Bone marrow
Clinical trials
Clinical Trials as Topic
Coronavirus Infections - therapy
Coronaviruses
COVID-19
Cytokines
Edema
Epidemics
Fever
Health aspects
Humans
Hypoxia
Immune clearance
Immune response
Immunomodulation
Immunomodulators
Infections
Inflammation
Intravenous administration
Lung diseases
Medical research
Mesenchymal Stem Cell Transplantation - adverse effects
Mesenchymal stem cells
Mesenchymal Stem Cells - cytology
Morbidity
Mortality
Neutrophils
Outbreaks
Pandemics
Pathogenesis
Patients
Pneumonia
Pneumonia, Viral - therapy
Pulmonary fibrosis
Respiratory diseases
Respiratory distress syndrome
Respiratory function
Review
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Stem cell transplantation
Stem cells
United Kingdom
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlh9JL6SNp3SZBhUAPRWQty7J0zJO0kARKE3KqkKURCTTeUO8W-u87kuVlTaC99GhrhC3NjOYbW_OJkD2LqAC8AgaNtUy0omZKecm0CsAFrpgilUefX8izK_Hlpr5ZO-or7gkb6IGHidsX3CotmhZtT4tSga295hyC1bUIwabEB2PemEyNLHuY9owlMkru9xjVcEGIqVKMUTPGJ2EosfU_XpPXgtJ0w-RaBDp9QZ5n6EgPhld-SZ5A94o8Pc8_x1-T71_zhz2giEQpIjs61j3SZQ90Hqj1dw_zHphHu_sFnt7H2iN3-_seRSKjM43f8fvU_ejy-vMxKzXNzKv9Jrk6Pfl2dMby8QnMSa4XDIGGBAm1423AVSw4B01TYcCXtlQzZ2ccbGirwJV1MvjGB7xqNYB22EtDtUU2unkHbwlF1NBwH__EI14RTrUaA16LYNF7ZatKFqQcZ9O4zC0ej7j4YVKOoaQZNGBQAyZpwPCCfFr1eRiYNf4qfRiVtJKMrNjpBtqKybZi_mUrBfkYVWyi7-LrOZtLEHCQkQXLHMSDiBDSSXzc9kQSfc5Nm0cjMdnne4PYCLGlnsXp-LBqjj3jPrYO5stBJmHCuiBvBptaDSlBWyF0QZqJtU3GPG3p7m4TI3iDuBgT6Xf_Y5Lek2c8OUrNSrVNNhY_l7CDwGvR7iYf-wPYmCiA
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA_HCeKL-G31lAiCDxLdpmmaPIicp8cprIK4ck-GNJl4B3ftud0V7793krbrFY973GaGbTJfv2k7M4Q8t4gKwCtgUFnLRC1KppSXTKsAXKDHFKk8ev5ZHizEp8PycIuM446GA-wuTe3iPKnF8uTVn1_nb9Hg3ySDV_J1hzELzT0mQjECzRi65GsYmapoqHOh_vXew2RoLJy5lG8SnFIP__899YVQNf2M8kJc2r9Fbg6Aku72GnCbbEFzh1yfD6_M75IfX4fHfUARn1LEe3SshqTrDmgbqPXHZ20HzKM2_gZPT2NFkjs6P0WS2OeZxqf7XWLf-_L943uWazr0Y-3ukcX-h297B2wYqsCc5HrFEH5IkFA6Xgf0bcE5qKoCYYC0uZo5O-NgQ10ErqyTwVc-4K9aA2iHXBqK-2S7aRt4SChiiYr7-H4eUYxwqtYYBmuEkN4rWxQyI_l4msYNHcfj4IsTkzIPJU0vAYMSMEkChmfk5YbnrO-3cSX1uyikDWXslZ0utMufZjA9I7hVWlQ1ei8tcgW29JpzCFaXIgSbZ-RFFLGJOoa35-xQmICbjL2xzG4cT4RAT-Lf7Uwo0RLddHlUEjMqskHEhIhTz-JxPNssR874dVsD7bqnSUixzMiDXqc2W0qAVwidkWqibZM9T1ea46PUJ7xCtIzp9aOrb-sxucGTCZQsVztke7VcwxMEWqv6abKev0MSI0w
  priority: 102
  providerName: Scholars Portal
Title Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients
URI https://www.ncbi.nlm.nih.gov/pubmed/32423449
https://www.proquest.com/docview/2404419036
https://www.proquest.com/docview/2404639935
https://pubmed.ncbi.nlm.nih.gov/PMC7232924
https://doaj.org/article/42a8947b3189418ea5d922efa954ffa1
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3daxQxEA_agvgifne1HhEEHyS0m8tmkyfp1ZYqXJXDyuGDIZtMbMHent07wf_eSS537SL0ZWE3CbvZ-fpNkpkh5I1FVABeAYPaWiYaUTGlvGRaBeACNaZI4dHjU3lyJj5Nq2lecOvyscq1TkyK2rcurpHvoeVBy61R4b6f_2axalTcXc0lNO6S7Zi6LB7pqqfXDpdA52cdKKPkXoe2DdVCdJiipdpnvGeMUs7-_zXzDdPUPzZ5ww4dPyQPMoCkByuKPyJ3YPaY3BvnLfIn5MckL-8BRTxKEd_RdfQjXXZA20Ctv5i3HTCP3PcHPL2MEUju_O8ldol5nWlcze_S8MPP3z5-YKWmOf9q95ScHR99PTxhuYgCc5LrBUO4IUFC5XgTUJcF56Cuh2j2pS3VvrP7HGxohoEr62TwtQ9412gA7XCUhuEzsjVrZ7BDKP79mvu4H4-oRTjVaDR7DUJG75UdDmVByvXfNC5nGI-FLn6Z5GkoaVYUMEgBkyhgeEHebcbMV_k1bu09ikTa9Iy5sdOD9uqnyaJmBLdKi7pBbaVFqcBWXnMOwepKhGDLgryNJDZRgvHznM2BCDjJmAvLHMRyRAjsJL5ut9cTJc_1m9dMYrLkd-aaTwvyetMcR8bTbDNol6s-CRlWBXm-4qnNlBLAFUIXpO5xW2_O_ZbZxXnKC14jOkZ3-sXtn_WS3OdJBCpWql2ytbhawisEVotmkKRnQLZHR6dfJoO0PIHXsVB4nYy-_wOhlCSX
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGJgEviDuBAUYC8YCsNa7j2A8I7aqWrQVNG9rTjOMLm8SasrSg_Sl-I8dO0i1C2tseG9tpnHP5Psc-5yD0VgMrcFY44nKtCStYRoSwnEjhHWXgMVkMjx6N-eCQfT7KjpbQ3zYWJhyrbH1idNS2NOEb-RogDyC3BIf7afqLhKpRYXe1LaFRq8Wuu_gDS7bq43AL5PuO0p3tg80BaaoKEMOpnBHAX-64ywwtPBi3N8bleR9wkOtU9IzuUad90fdUaMO9za2HX4V0ThoYJV0f7nsLrcA8euAIVja2x1_3L7P7wXKrDc0RfK0CNAVHFJZoARt7hHbgL1YJ-B8LroBh96DmFeTbuY_uNZQVr9c69gAtuclDdHvUbMo_Qsf7zQdFh4EBY2CUuI23xPPK4dJjbU-nZeWIBX3_7Sw-CzFP5uTiDLqETNI47B9Ucfjml2_DLZJK3GR8rR6jwxt5wU_Q8qScuGcIg7xzasMJAOBJzIhCAtAWQFKtFbrf5wlK27epTJPTPJTW-Kni2kZwVUtAgQRUlICiCfqwGDOtM3pc23sjCGnRM2TjjhfK8x-qMW7FqBaS5QX4R8lS4XRmJaXOa5kx73WaoPdBxCr4DHg8o5vQB5hkyL6l1kMBJKCSHP5utdMTbN10m1slUY2vqdSlZSTozaI5jAzn5yaunNd9IhfNEvS01qnFlCKlZkwmKO9oW2fO3ZbJ6UnMRJ4DH4cF_PPrH-s1ujM4GO2pveF49wW6S6M5ZCQVq2h5dj53L4HWzYpXjS1h9P2mzfcfzJliCA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rationale+for+the+clinical+use+of+adipose-derived+mesenchymal+stem+cells+for+COVID-19+patients&rft.jtitle=Journal+of+translational+medicine&rft.au=Rogers%2C+Christopher+J&rft.au=Harman%2C+Robert+J&rft.au=Bunnell%2C+Bruce+A&rft.au=Schreiber%2C+Martin+A&rft.date=2020-05-18&rft.pub=BioMed+Central&rft.eissn=1479-5876&rft.volume=18&rft.spage=1&rft_id=info:doi/10.1186%2Fs12967-020-02380-2
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1479-5876&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1479-5876&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1479-5876&client=summon